Effect of erythropoietin therapy and withdrawal on blood coagulation and fibrinolysis in hemodialysis patients

Kidney International

Volumn 44, Issue 1, 1993, Pages 182-190

  Taylor, J E ^a   Belch, J J F ^a   McLaren, M ^a   Henderson, I S ^a   Stewart, W K ^a  

^a NINEWELLS HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ERYTHROPOIETIN; RECOMBINANT ERYTHROPOIETIN;

ADULT; ANEMIA; ARTICLE; BLOOD CLOTTING; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FIBRINOLYSIS; HEMODIALYSIS; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0027190911     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1038/ki.1993.229     Document Type: Article

References (43)

1. Canadian Erythropoietin Study Group Association between recombinant human erythropoietin and quality of life and exercise capacity of patients receiving haemodialysis Br Med J 300 1990 573 578
2. E. Sundal J. Businger A. Kappeler Treatment of transfusion-dependent anaemia of chronic renal failure with recombinant human erythropoietin Nephrol Dial Transplant 6 1991 955 965
3. M.E. Edmunds J. Walls B. Tucker Seizures in haemodialysis patients treated with recombinant human erythropoietin Nephrol Dial Transplant 4 1989 1065 1069
4. S. Heidenreich K-H Rahn W. Zidek Direct vasopressor effect of recombinant human erythropoietin on renal resistance vessels Kidney Int 39 1991 259 265
5. A.E.G. Raine Seizures and hypertension events Semin Nephrol 10 1990 40 50
6. A. Slingeneyer B. Faller B. Laroche B. Ehmer C. Mion Self-administered daily subcutaneous recombinant human erythropoietin: An open randomised dose-finding study in ESRD patients receiving peritoneal dialysis Contrib Nephrol 88 1991 159 168
7. I.C. Macdougall D.E. Roberts P. Neubert A.D. Dhamasena G.A. Coles J.D. Williams Pharmacokinetics of recombinant human erythropoietin in patients on continuous ambulatory peritoneal dialysis Lancet i 1989 425 427
8. C. Van Geet D. Hauglustaine L. Verresen M. Vanrusselt J. Vermylen Haemostatic effects of recombinant human erythropoietin on chronic haemodialysis patients Thromb Haemostas 61 1989 117 121
9. T. Akizawa E. Kinugasa T. Kitaoka S. Koshikawa Effects of recombinant human erythropoietin and correction of anaemia on platelet function in haemodialysis patients Nephron 58 1991 400 406
10. J.E. Taylor I.S. Henderson W.K. Stewart J.J.F. Belch Platelet aggregation in erythropoietin treated patients Platelets 3 1992 47 52
11. J.J. Zwaginga M.J.W. Ijsseldijk P.G. de Groot M. Kooistra J. Vos A. Van Es H.A. Koomans A. Struyvenberg J.J. Sixma Treatment of uraemic anaemia with recombinant erythropoietin also reduces the defects in platelet adhesion and aggregation caused by uraemic plasma Thromb Haemostas 66 1991 638 647
12. A. Cases G. Escolar J.C. Reverter A. Ordinas J. Lopez-Pedret L. Revert R. Castillo Recombinant human erythropoietin treatment improves platelet function in uraemic patients Kidney Int 42 1992 668 672
13. I.C. Macdougall M.E. Davies I. Hallett D.L. Cochlin R.D. Hutton G.A. Coles J.D. Williams Coagulation studies and fistula blood flow during erythropoietin therapy in haemodialysis patients Nephrol Dial Transplant 6 1991 862 867
14. J.E. Taylor M. McLaren I.S. Henderson J.J.F. Belch W.K. Stewart Prothrombotic effect of erythropoietin in dialysis patients Nephrol Dial Transplant 7 1992 235 239
15. S. Huraib A.K. Al-Momen A.M.A. Gader A. Mitwalli F. Sulimani H. Abu-Aisha Effect of recombinant human erythropoietin (rHuEPO) on the hemostatic system in chronic hemodialysis patients Clin Nephrol 36 1991 252 257
16. J. Szewczuk M. Mazerska J. Malyszko M. Kalinowski M. Mysliwiec Increase in fibrinolytic activity after erythropoietin therapy Thromb Haemostas 67 1992 284 (letter)
17. J.E. Taylor I.S. Henderson R.A. Mactier W.K. Stewart Effects of withdrawing erythropoietin Br Med J 302 1991 272 273
18. J.E. Taylor R.A. Mactier W.K. Stewart I.S. Henderson Effect of erythropoietin on anaemia in patients with myeloma receiving haemodialysis Br Med J 301 1990 476 477
19. M. McLaren I.A. Greer J.J. Walker C.D. Forbes Umbilical artery perfusion: A method to measure prostacyclin production in vitro Prog Lipid Res 25 1986 311 315
20. D. Prisco F. Bonechi M. Boddi Thrombin-antithrombin (TAT) complexes in hypercoagulable states Thromb Haemostas 62 1989 449 (abstract)
21. A.R. Saniabadi T.C. Fisher A.R. Rimmer J.J.F. Belch C.D. Forbes A study of the effect of dipyridamole on erythrocyte deformability using an improved filtration technique Clin Haemorrheol 10 1990 262 274
22. T.C. Fisher J.J.F. Belch J.C. Barbenel A.C. Fisher In vitro human whole blood granulocyte aggregation Clin Sci 76 1989 183 187
23. M. Hills P. Armitage The two period crossover clinical trial Br J Clin Pharmac 8 1979 7 20
24. K.T. Preissner Biological relevance of the protein C system and laboratory diagnosis of protein C and protein S deficiencies Clin Sci 78 1990 351 364
25. A.E.G. Raine Hypertension, blood viscosity, and cardiovascular morbidity in renal failure: Implications of erythropoietin therapy Lancet i 1988 97 100
26. B.A. Gilchrest J.W. Rowe M.C. Mihm Clinical and histological skin changes in chronic renal failure: Evidence for a dialysis-resistant, transplant-responsive, microangiopathy Lancet ii 1980 1271 1275
27. L. Goodnough S. Rudnick T. Price S.K. Ballas M.L. Collins J.P. Crowley M. Kosmin M.S. Kruskall B.A. Lenes J.E. Menitove L.E. Silberstein K.J. Smith C.H. Wallas R. Abels M. Von Tress Increased pre-operative collection of autologous blood with recombinant human erythropoietin therapy N Engl J Med 321 1989 1163 1168
28. M.P. GordGe N.J. Dodd P.B. Rylance M.J. Weston An assessment of whole blood impedence aggregometry using blood from normal subjects and haemodialysis patients Thromb Res 36 1984 17 27
29. A.R. Saniabadi G.D.O. Lowe J.C. Barbenel C.D. Forbes Further studies on the role of red blood cells in spontaneous platelet aggregation Thromb Res 38 1985 225 232
30. V.T. Turitto H.J. Weiss Red blood cells: Their dual role in thrombus formation Science 207 1980 541 543
31. W. Inauen M. Staubli C. Descoeudres R.L. Galeazzi P.W. Straub Erythrocyte deformability in dialysed and non-dialysed uraemic patients Eur J Clin Invest 12 1982 173 176
32. A.G. Hocken Haemolysis in chronic renal failure Nephron 32 1982 28 31
33. A. Saniabadi G.D.O. Lowe R. Madhok K. Spowart B. Shaw J.C. Barbenel C.D. Forbes Red blood cells mediate spontaneous aggregation of platelets in whole blood Atherosclerosis 66 1987 175 180
34. V.T. Turitto H.J. Weiss H.R. Baumgartner Platelet interaction with rabbit subendothelium in von Willebrand's Disease: Altered thrombus formation distinct from defective platelet adhesion J Clin Invest 74 1984 1730 1741
35. J.J.F. Belch A.A. Zoma I.M. Richards I.C. McLaughlin C.D. Forbes R.D. Sturrock Vascular damage and factor-VIII-related antigen in the rheumatic diseases Rheumatol Int 7 1987 107 111
36. H.R. Gralnick L.P. McKeown S.S. Williams B.C. Shafer L. Pierce Plasma and platelet von Willebrand Factor defects in uraemia Am J Med 85 1988 806 810
37. E.N. Dessypris J.H. Gleaton O.L. Armstrong Effect of human recombinant erythropoietin on human marrow megakaryocyte colony formation in vitro Br J Haematol 65 1987 265 269
38. J.C. Giddings L.R. Brookes F. Piovella A.L. Bloom Immunohistological comparison of platelet factor 4 (PF4), fibronectin (Fn) and factor VIII related antigen (VIIIRAg) in human platelet granules Br J Haematol 52 1982 79 88
39. T.W. Meade M.V. Vickers S.G. Thompson Y. Stirling A.P. Haines G.J. Miller Epidemiological characteristics of platelet aggregability Br Med J 290 1985 428 432
40. R. Koppensteiner F. Stockenhuber C. Jahn P. Balcke E. Minar H. Ehringer Changes in determinants of blood rheology during treatment with haemodialysis and recombinant human erythropoietin Br Med J 300 1990 1626 1627
41. M.P. Gordge R.W. Faint P.B. Rylance H. Ireland D.A. Lane G.H. Neild Plasma D-dimer: A useful marker of fibrin breakdown in renal failure Thromb Haemostas 61 1989 522 525
42. G. Defreyn M. Vergara Dauden S.J. Machin J. Vermylen A plasma factor in uraemia which stimulates prostacyclin release from cultured endothelial cells Thromb Res 19 1980 695 699
43. J.J.F. Belch The role of the white blood cell in arterial disease Blood Coag Fibrinol 1 1990 183 192